Genpact Limited (NYSE:G - Get Free Report) announced a quarterly dividend on Friday, June 6th, RTT News reports. Stockholders of record on Wednesday, June 18th will be given a dividend of 0.17 per share by the business services provider on Monday, June 30th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.58%.
Genpact has raised its dividend by an average of 12.4% per year over the last three years and has raised its dividend annually for the last 6 consecutive years. Genpact has a payout ratio of 18.2% meaning its dividend is sufficiently covered by earnings. Analysts expect Genpact to earn $3.49 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 19.5%.
Genpact Stock Up 2.4%
G traded up $0.99 on Friday, reaching $43.09. 1,606,953 shares of the company traded hands, compared to its average volume of 1,374,726. The company has a market cap of $7.54 billion, a price-to-earnings ratio of 15.17, a PEG ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock's 50 day moving average price is $46.13 and its 200-day moving average price is $47.22. Genpact has a 52-week low of $30.38 and a 52-week high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The company had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. During the same quarter last year, the business posted $0.73 EPS. The company's revenue for the quarter was up 7.4% on a year-over-year basis. On average, sell-side analysts expect that Genpact will post 3.21 EPS for the current fiscal year.
Insiders Place Their Bets
In other Genpact news, Director Nicholas C. Gangestad purchased 2,000 shares of the firm's stock in a transaction on Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the purchase, the director now directly owns 2,000 shares of the company's stock, valued at approximately $87,940. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20% decrease in their position. The disclosure for this sale can be found here. Company insiders own 3.07% of the company's stock.
Hedge Funds Weigh In On Genpact
A number of hedge funds and other institutional investors have recently made changes to their positions in G. Amundi acquired a new stake in shares of Genpact in the 1st quarter valued at $58,000. Focus Partners Wealth boosted its position in Genpact by 10.3% in the first quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider's stock valued at $263,000 after buying an additional 488 shares in the last quarter. Royal Bank of Canada boosted its position in Genpact by 19.7% in the first quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider's stock valued at $6,131,000 after buying an additional 20,043 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Genpact by 20.8% during the first quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider's stock worth $17,788,000 after buying an additional 60,887 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Genpact by 12.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider's stock valued at $25,776,000 after acquiring an additional 56,557 shares during the last quarter. 96.03% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several brokerages have recently commented on G. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and increased their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC cut their target price on Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, May 8th. Robert W. Baird reduced their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Finally, Mizuho increased their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $50.71.
Read Our Latest Research Report on Genpact
About Genpact
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report